199 related articles for article (PubMed ID: 28253895)
1. EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
Beca F; Kensler K; Glass B; Schnitt SJ; Tamimi RM; Beck AH
Breast Cancer Res; 2017 Mar; 19(1):21. PubMed ID: 28253895
[TBL] [Abstract][Full Text] [Related]
2. Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.
Inari H; Suganuma N; Kawachi K; Yoshida T; Yamanaka T; Nakamura Y; Yoshihara M; Nakayama H; Yamanaka A; Masudo K; Oshima T; Yokose T; Rino Y; Shimizu S; Miyagi Y; Masuda M
BMC Cancer; 2017 Feb; 17(1):160. PubMed ID: 28241804
[TBL] [Abstract][Full Text] [Related]
3. The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women.
Huh SJ; Oh H; Peterson MA; Almendro V; Hu R; Bowden M; Lis RL; Cotter MB; Loda M; Barry WT; Polyak K; Tamimi RM
Cancer Res; 2016 Apr; 76(7):1926-34. PubMed ID: 26941287
[TBL] [Abstract][Full Text] [Related]
4. EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development.
Kunju LP; Cookingham C; Toy KA; Chen W; Sabel MS; Kleer CG
Mod Pathol; 2011 Jun; 24(6):786-93. PubMed ID: 21399615
[TBL] [Abstract][Full Text] [Related]
5. High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.
Lobo J; Rodrigues Â; Antunes L; Graça I; Ramalho-Carvalho J; Vieira FQ; Martins AT; Oliveira J; Jerónimo C; Henrique R
Urol Oncol; 2018 Apr; 36(4):161.e7-161.e17. PubMed ID: 29174711
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor levels in nonneoplastic breast epithelium of breast cancer cases versus benign breast biopsy controls.
Woolcott CG; SenGupta SK; Hanna WM; Aronson KJ
BMC Cancer; 2008 May; 8():130. PubMed ID: 18466613
[TBL] [Abstract][Full Text] [Related]
7. EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.
Guo S; Li X; Rohr J; Wang Y; Ma S; Chen P; Wang Z
Diagn Pathol; 2016 Apr; 11():41. PubMed ID: 27113214
[TBL] [Abstract][Full Text] [Related]
8. EZH2 Protein Expression in Estrogen Receptor Positive Invasive Breast Cancer Treated With Neoadjuvant Endocrine Therapy: An Exploratory Study of Association With Tumor Response.
Gan Y; Lo Y; Makower D; Kleer C; Lu J; Fineberg S
Appl Immunohistochem Mol Morphol; 2022 Oct; 30(9):614-622. PubMed ID: 36048167
[TBL] [Abstract][Full Text] [Related]
9. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
Wu J; Crowe DL
Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
[TBL] [Abstract][Full Text] [Related]
10. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2006 Sep; 107(6):1240-7. PubMed ID: 16902983
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study.
Posso M; Corominas JM; Serrano L; Román M; Torá-Rocamora I; Domingo L; Romero A; Quintana MJ; Vernet-Tomas M; Baré M; Vidal C; Sánchez M; Saladié F; Natal C; Ferrer J; Servitja S; Sala M; Castells X;
Cancer Med; 2017 Jun; 6(6):1482-1489. PubMed ID: 28470951
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma.
Ho TH; Kapur P; Eckel-Passow JE; Christie A; Joseph RW; Serie DJ; Cheville JC; Thompson RH; Homayoun F; Panwar V; Brugarolas J; Parker AS
J Clin Oncol; 2017 Nov; 35(32):3706-3713. PubMed ID: 28976794
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor expression in benign breast epithelium and breast cancer risk.
Khan SA; Rogers MA; Khurana KK; Meguid MM; Numann PJ
J Natl Cancer Inst; 1998 Jan; 90(1):37-42. PubMed ID: 9428781
[TBL] [Abstract][Full Text] [Related]
14. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
15. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.
Collett K; Eide GE; Arnes J; Stefansson IM; Eide J; Braaten A; Aas T; Otte AP; Akslen LA
Clin Cancer Res; 2006 Feb; 12(4):1168-74. PubMed ID: 16489070
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
[TBL] [Abstract][Full Text] [Related]
17. Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus.
Nehme Z; Pasquereau S; Haidar Ahmad S; El Baba R; Herbein G
EBioMedicine; 2022 Jun; 80():104056. PubMed ID: 35596973
[TBL] [Abstract][Full Text] [Related]
18. Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA.
Kumari K; Das B; Adhya A; Chaudhary S; Senapati S; Mishra SK
Cell Death Dis; 2018 Feb; 9(2):152. PubMed ID: 29396474
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit Is Required for Uterine Epithelial Integrity.
Fang X; Ni N; Lydon JP; Ivanov I; Bayless KJ; Rijnkels M; Li Q
Am J Pathol; 2019 Jun; 189(6):1212-1225. PubMed ID: 30954472
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
